Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3452)
All Articles published online
|
May 21, 2008 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Socoteanu MP, Mott F, Alpini G, Frankel AE. c-Met targeted therapy of cholangiocarcinoma. World J Gastroenterol 2008; 14(19): 2990-2994 [PMID: 18494048 DOI: 10.3748/wjg.14.2990] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v14/i19/2990.htm |
| Number | Citing Articles |
| 1 |
Gianfranco D. Alpini, Heather L. Francis, Marco Marzioni, Domenico Alvaro, Eugenio Gaudio, Ivano Lorenzini, Antonio Benedetti, Giammarco Fava. Molecular Pathology of Liver Diseases. Molecular Pathology Library 2011; 5: 867 doi: 10.1007/978-1-4419-7107-4_59
|
| 2 |
H. J. Park, K. Kim, J. H. Paik, E. K. Chie, S. Kim, J.-Y. Jang, S. W. Kim, S.-W. Han, D.-Y. Oh, S.-A. Im, T.-Y. Kim, Y.-J. Bang, S. W. Ha. Is c-Met oncoprotein expression an adverse prognosticator in extrahepatic bile duct cancer treated with curative resection followed by adjuvant chemoradiotherapy?. Clinical and Translational Oncology 2016; 18(6): 625 doi: 10.1007/s12094-015-1409-5
|
| 3 |
Jung Han Kim, Hyeong Su Kim, Bum Jun Kim, Jin Lee, Hyun Joo Jang. Prognostic value of c-Met overexpression in pancreatic adenocarcinoma: a meta-analysis. Oncotarget 2017; 8(42): 73098 doi: 10.18632/oncotarget.20392
|
| 4 |
Hector Perez-Montoyo. Therapeutic Potential of Autophagy Modulation in Cholangiocarcinoma. Cells 2020; 9(3): 614 doi: 10.3390/cells9030614
|
| 5 |
Xiaofang Zhao, Guosong Luo, Ying Cheng, Wenjing Yu, Run Chen, Bin Xiao, Yuancai Xiang, Chunhong Feng, Wenguang Fu, Chunyan Duan, Fuli Yao, Xianming Xia, Qinghua Tao, Mei Wei, Rongyang Dai. Compound C induces protective autophagy in human cholangiocarcinoma cells via Akt/mTOR‐independent pathway. Journal of Cellular Biochemistry 2018; 119(7): 5538 doi: 10.1002/jcb.26723
|
| 6 |
THITINEE VANICHAPOL, KAWIN LEELAWAT, SURADEJ HONGENG. Hypoxia enhances cholangiocarcinoma invasion through activation of hepatocyte growth factor receptor and the extracellular signal-regulated kinase signaling pathway. Molecular Medicine Reports 2015; 12(3): 3265 doi: 10.3892/mmr.2015.3865
|
| 7 |
Abigail Claus, Allison Sweeney, Deeksha M. Sankepalle, Brian Li, Daniel Wong, Marvin Xavierselvan, Srivalleesha Mallidi. 3D Ultrasound-Guided Photoacoustic Imaging to Monitor the Effects of Suboptimal Tyrosine Kinase Inhibitor Therapy in Pancreatic Tumors. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.915319
|
| 8 |
Abigail Zabron, Robert J. Edwards, Shahid A. Khan. The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer. Disease Models & Mechanisms 2013; 6(2): 281 doi: 10.1242/dmm.010561
|
| 9 |
Vincent Chung. Systemic Therapy for Hepatocellular Carcinoma and Cholangiocarcinoma. Surgical Oncology Clinics of North America 2015; 24(1): 187 doi: 10.1016/j.soc.2014.09.009
|
| 10 |
M Miyamoto, H Ojima, M Iwasaki, H Shimizu, A Kokubu, N Hiraoka, T Kosuge, D Yoshikawa, T Kono, H Furukawa, T Shibata. Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma. British Journal of Cancer 2011; 105(1): 131 doi: 10.1038/bjc.2011.199
|
| 11 |
Roland Kaufmann, Alexander Hascher, Franziska Mußbach, Petra Henklein, Kathrin Katenkamp, Martin Westermann, Utz Settmacher. Proteinase-activated receptor 2 (PAR2) in cholangiocarcinoma (CCA) cells: effects on signaling and cellular level. Histochemistry and Cell Biology 2012; 138(6): 913 doi: 10.1007/s00418-012-1006-4
|
| 12 |
Fangda Li, Malalage N. Peiris, Daniel J. Donoghue. Functions of FGFR2 corrupted by translocations in intrahepatic cholangiocarcinoma. Cytokine & Growth Factor Reviews 2020; 52: 56 doi: 10.1016/j.cytogfr.2019.12.005
|
| 13 |
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Athanasios G Papavassiliou, Michalis V Karamouzis. Role of autophagy in cholangiocarcinoma: An autophagy-based treatment strategy. World Journal of Gastrointestinal Oncology 2021; 13(10): 1229-1243 doi: 10.4251/wjgo.v13.i10.1229
|
| 14 |
Wen-Sheng Wu, Rui-Fang Chen, Chuan-Chu Cheng, Jia-Ling Wei, Chen-Fang Lin, Ren-In You, Yen-Chang Chen, Ming-Che Lee, Yen-Cheng Chen. Suppressing of Src–Hic-5–JNK–AKT Signaling Reduced GAPDH Expression for Preventing the Progression of HuCCT1 Cholangiocarcinoma. Pharmaceutics 2022; 14(12): 2698 doi: 10.3390/pharmaceutics14122698
|
| 15 |
Melanie Byrne Thomas. Systemic and Targeted Therapy for Biliary Tract Tumors and Primary Liver Tumors. Surgical Oncology Clinics of North America 2014; 23(2): 369 doi: 10.1016/j.soc.2013.11.004
|
| 16 |
Aileen Deng, Steven Cohen. Primary and Metastatic Liver Tumors. 2018; : 137 doi: 10.1007/978-3-319-91977-5_11
|
| 17 |
Manuela Gatto, Maria Consiglia Bragazzi, Rossella Semeraro, Cristina Napoli, Raffaele Gentile, Alessia Torrice, Eugenio Gaudio, Domenico Alvaro. Cholangiocarcinoma: Update and future perspectives. Digestive and Liver Disease 2010; 42(4): 253 doi: 10.1016/j.dld.2009.12.008
|
| 18 |
Carryn Anderson, Richard Kim. Adjuvant therapy for resected extrahepatic cholangiocarcinoma: A review of the literature and future directions. Cancer Treatment Reviews 2009; 35(4): 322 doi: 10.1016/j.ctrv.2008.11.009
|
| 19 |
Zhi-Yuan Mao, Guang-Qing Zhu, Li Ren, Xiao-Chuan Guo, Dan Su, Li Bai. Prognostic Value of C-met Expression in Cholangiocarcinoma. Technology in Cancer Research & Treatment 2016; 15(2): 227 doi: 10.1177/1533034615578959
|
| 20 |
Ana F. Brito, Ana M. Abrantes, João C. Encarnação, José G. Tralhão, Maria F. Botelho. Cholangiocarcinoma: from molecular biology to treatment. Medical Oncology 2015; 32(11) doi: 10.1007/s12032-015-0692-x
|
| 21 |
Peter L. Labib, George Goodchild, Stephen P. Pereira. Molecular Pathogenesis of Cholangiocarcinoma. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5391-0
|
| 22 |
Iwona Gisterek, Rafał Matkowski, Elzbieta Suder, Agnieszka Hałoń, Jolanta Szelachowska, Ewelina Łata, Aleksandra Łacko, Przemysław Biecek, Jan Kornafel. Correlation between hepatocyte growth factor receptor and vascular endothelial growth factor-A in breast carcinoma.. Folia Histochemica et Cytobiologica 2010; 48(1) doi: 10.2478/v10042-010-0016-0
|
| 23 |
Cindy Lobe, Marie Vallette, Ander Arbelaiz, Ester Gonzalez‐Sanchez, Laura Izquierdo, Anna Pellat, Nathalie Guedj, Corentin Louis, Valérie Paradis, Jesus M Banales, Cédric Coulouarn, Chantal Housset, Javier Vaquero, Laura Fouassier. Zinc Finger E‐Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor–Stroma Paracrine Signaling. Hepatology 2021; 74(6): 3194 doi: 10.1002/hep.32069
|
| 24 |
Chen Chen, Dinghua Yang, Qinghua Zeng, Liang Luo, Chengzhi Cai. PF-2341066 combined with celecoxib promotes apoptosis and inhibits proliferation in human cholangiocarcinoma QBC939 cells. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.5967
|
| 25 |
Melanie B. Thomas. Biliary Tract and Gallbladder Cancer. Medical Radiology 2014; : 275 doi: 10.1007/978-3-642-40558-7_18
|
| 26 |
Pattaya Seeree, Phorutai Pearngam, Supeecha Kumkate, Tavan Janvilisri. An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma. International Journal of Genomics 2015; 2015: 1 doi: 10.1155/2015/179528
|
| 27 |
|
| 28 |
Francesco M. Serafini, David Radvinsky. The pathways of genetic transformation in cholangiocarcinogenesis. Cancer Genetics 2016; 209(12): 554 doi: 10.1016/j.cancergen.2016.07.004
|